“How Much to Invest in Glycemic Control of a Patient With Diabetes Mellitus Type 2? A Constant Dilemma for the Brazilian Public Health System (SUS)”. 2019. Brazilian Journal of Pharmaceutical Sciences 55 (November): e17197. https://doi.org/10.1590/s2175-97902019000117197.